Table 1: Comparison of patient characteristics between liposomal bupivacaine and standard bupivacaine groups.

 

LB

SB

p

Number of Subjects

40

40

 

 

 

 

 

Age (mean ± SD)

57.1 ± 14.1

63.1 ± 8.6

0.0256

 

 

 

 

Male

21 (52.5%)

24 (60.0%)

0.4990 

Female

19 (47.5%)

16 (40.0%)

 

 

 

 

 

Diabetes

5 (12.5%)

6 (15.0%)

0.7454 

COPD

4 (10.0%)

2 (5.0%)

0.6752 

CAD

1 (2.5%)

5 (12.5%)

0.2007 

Chronic pain requiring daily opioid

2 (5.0%)

0

0.4397 

 

 

 

 

BMI (mean ± SD)

31.6 ± 6.1

31.3 ± 5.8

0.7956 

 

 

 

 

Arthroscopy

31 (77.5%)

30 (75.0%)

0.7928 

Arthroplasty

9 (22.5%)

10 (25.0%)

 

Abbreviations: LB: Liposomal Bupivacaine; SB: Standard Bupivacaine; SD: Standard Deviation; COPD: Chronic Obstructive Pulmonary Disease; CAD: Coronary Artery Disease; BMI: Body Mass Index